GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Depomed, Inc. (DEPO) [hlAlert]

Rating:
Buy DEPO
up 41.59 %

Depomed, Inc. (DEPO) upgraded to Buy with price target $33 by WallachBeth

Posted on: Wednesday,  Nov 11, 2015  8:25 AM ET by WallachBeth

WallachBeth rated Buy Depomed, Inc. (NASDAQ: DEPO) on 11/11/2015, when the stock price was $20.34. Since
then, Depomed, Inc. has gained 41.59% as of 01/07/2016's recent price of $28.80.
If you would have followed this WallachBeth's recommendation on DEPO, you would have gained 41.59% of your investment in 57 days.

Depomed, Inc. (Depomed) is a specialty pharmaceutical company focused on the development and commercialization of differentiated products that are based on oral drug delivery technologies. Depomed has developed two commercial products: GLUMETZA (metformin hydrochloride extended release tablets), which is a once-daily treatment for adults with type 2 diabetes that it commercializes in the United States with Santarus, Inc. (Santarus). ProQuin XR (ciprofloxacin hydrochloride extended release tablets), which is a once-daily treatment for uncomplicated urinary tract infections that Depomed commercializes in the United States with Watson Pharma (Watson).

WallachBeth
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/11/2015 8:25 AM Buy
None
20.34 33.00
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/24/2015 11:25 AM Hold
None
32.73 33.00
3/13/2015 8:25 AM Hold
None
24.31 26.00
2/25/2013 9:25 AM Hold
None
6.28 7.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy